Search in:

Advanced search

Cancer Management and Research Volume 10, 2018 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Original Research

Pegaspargase, gemcitabine, dexamethasone, and cisplatin (P-GDP) combined chemotherapy is effective for newly diagnosed extranodal NK/T-cell lymphoma: a retrospective study

Tao LiuCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, [email protected]

Fang ZhuCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, [email protected]

Yin XiaoCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, [email protected]

Qiuhui LiCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, [email protected]

Xinxiu LiuCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, [email protected]

Kunyu YangCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, [email protected]

Gang WuCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, [email protected]

Liling ZhangCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, [email protected]Correspondence[email protected]

show all

Pages 5061-5069 | Published online: 29 Oct 2018

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

TseEKwongYLHow I treat NK/T-cell lymphomasBlood2013121254997500523652805
PubMed Web of Science ®Google Scholar
AuWYWeisenburgerDDIntragumtornchaiTClinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma ProjectBlood2009113173931393719029440
PubMed Web of Science ®Google Scholar
AuWYMaSYChimCSClinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 yearsAnn Oncol200516220621415668271
PubMed Web of Science ®Google Scholar
KimSJKimKKimBSPhase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-cell lymphoma: Consortium for Improving Survival of Lymphoma studyJ Clin Oncol200927356027603219884539
PubMed Web of Science ®Google Scholar
YamaguchiMTobinaiKOguchiMConcurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: an updated analysis of the Japan clinical oncology group study JCOG0211J Clin Oncol201230324044404623045573
PubMed Web of Science ®Google Scholar
BiXWXiaYZhangWWRadiotherapy and PGEMOX/GELOX regimen improved prognosis in elderly patients with early-stage extra-nodal NK/T-cell lymphomaAnn Hematol20159491525153325957850
PubMed Web of Science ®Google Scholar
KwongYLNatural killer-cell malignancies: diagnosis and treatmentLeukemia200519122186219416179910
PubMed Web of Science ®Google Scholar
YamaguchiMKitaKMiwaHFrequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cellsCancer19957611235123568635042
PubMed Web of Science ®Google Scholar
JaccardAGachardNMarinBEfficacy of l-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 studyBlood201111761834183921123825
PubMed Web of Science ®Google Scholar
YamaguchiMKwongYLKimWSPhase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group studyJ Clin Oncol201129334410441621990393
PubMed Web of Science ®Google Scholar
KwongYLKimWSLimSTSMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study GroupBlood2012120152973298022919026
PubMed Web of Science ®Google Scholar
YamaguchiMSuzukiROguchiMAdvances in the treatment of extra-nodal NK/T-cell lymphoma, nasal typeBlood2018131232528254029602763
PubMed Web of Science ®Google Scholar
EscherichGZur StadtUZimmermannMHorstmannMACoALL Study GroupClofarabine in combination with pegylated asparaginase in the frontline treatment of childhood acute lymphoblastic leukaemia: a feasibility report from the CoALL 08-09 trialBr J Haematol2013163224024723937310
PubMed Web of Science ®Google Scholar
WangJJDongMHeXHGDP (gemcitabine, dexamethasone, and cisplatin) is highly effective and well-tolerated for newly diagnosed stage IV and relapsed/refractory extranodal natural killer/T-cell lymphoma, nasal typeMedicine2016956e278726871836
PubMed Web of Science ®Google Scholar
ZhouZLiXChenCEffectiveness of gemcitabine, pegaspargase, cisplatin, and dexamethasone (DDGP) combination chemotherapy in the treatment of relapsed/refractory extranodal NK/T cell lymphoma: a retrospective study of 17 patientsAnn Hematol201493111889189424923454
PubMed Web of Science ®Google Scholar
ZhangLZhuFXiaoYPhase II study of concurrent chemoradiotherapy followed by Peg-Asp-GDP for localized nasal NK/T-cell lymphoma: a prospective single-center clinical trialHematol Oncol201533299
Google Scholar
ChesonBDPfistnerBJuweidMERevised response criteria for malignant lymphomaJ Clin Oncol200725557958617242396
PubMed Web of Science ®Google Scholar
YamaguchiMSuzukiRKwongYLPhase I study of dexamethasone, methotrexate, ifosfamide, l-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemiaCancer Sci20089951016102018294294
PubMed Web of Science ®Google Scholar
AhnHKKimSJHwangDWGemcitabine alone and/or containing chemotherapy is efficient in refractory or relapsed NK/T-cell lymphomaInvest New Drugs201331246947223108598
PubMed Web of Science ®Google Scholar
SallahSWanJYNguyenNPTreatment of refractory T-cell malignancies using gemcitabineBr J Haematol2001113118518711328299
PubMed Web of Science ®Google Scholar
ParkBBKimWSSuhCSalvage chemotherapy of gemcitabine, dexamethasone, and cisplatin (GDP) for patients with relapsed or refractory peripheral T-cell lymphomas: a consortium for improving survival of lymphoma (CISL) trialAnn Hematol201594111845185126251158
PubMed Web of Science ®Google Scholar
LiXCuiYSunZDDGP versus SMILE in newly diagnosed advanced natural killer/T-cell lymphoma: a randomized controlled, multicenter, open-label study in ChinaClin Cancer Res201622215223522827060152
PubMed Web of Science ®Google Scholar

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Pegaspargase, gemcitabine, dexamethasone, and cisplatin (P-GDP) combined chemotherapy is effective for newly diagnosed extranodal NK/T-cell lymphoma: a retrospective study

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Pegaspargase, gemcitabine, dexamethasone, and cisplatin (P-GDP) combined chemotherapy is effective for newly diagnosed extranodal NK/T-cell lymphoma: a retrospective study

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date